$MMSI News

Merit Medical Systems Inc (NASDAQ:MMSI) Shines in Caviar Cruise Quality Investing Screen with Strong Growth and High Profit Quality

Merit Medical Systems, Inc. (MMSI) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Merit Medical Systems, Inc. 2026 Q1 - Results - Earnings Call Presentation

Merit Medical Systems: Creating More Growth Engines (Rating Upgrade)

Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $85

JP Morgan Maintains Overweight on Merit Medical Systems, Lowers Price Target to $77

Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Lowers Price Target to $74

Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $90

Merit Medical Systems, Inc. (MMSI) Q1 2026 Earnings Call Transcript

Merit Medical Systems Inc (NASDAQ:MMSI) Beats Q1 Estimates but Sees Muted Market Reaction

Merit Medical Systems Q1 2026 Earnings Call Transcript

Merit Medical Systems Affirms FY2026 Adj EPS Guidance of $4.01-$4.15 vs $4.03 Est; Raises FY2026 Sales Guidance from $1.610B-$1.630B to $1.612B-$1.634B vs $1.619B Est

Merit Medical Systems Q1 Adj. EPS $0.94 Beats $0.83 Estimate, Sales $381.877M Beat $377.632M Estimate

Merit Medical Systems Inc. (NASDAQ:MMSI) Qualifies as a Top Quality Investment on the Caviar Cruise Screen

Barrington Research Maintains Outperform on Merit Medical Systems, Lowers Price Target to $107

Piper Sandler Maintains Overweight on Merit Medical Systems, Lowers Price Target to $96

FDA Warns Of Injury Risk Linked To Merit Medical Dialysis Kits

FDA Says Aware That Merit Medical Issued Letter To Affected Customers Recommending Some Dialysis Catheters Be Removed From Where They Are Used/ Sold; As Of Feb 23, Merit Medical Has Reported Two Serious Injuries & No Deaths Associated With Some Certain Dialysis Catheters

Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $90

Merit Medical Systems Acquires View Point Medical For ~$140M